Profound Medical Corp.
PRN.TO
Get informed when a big investor buys or sells
+ FollowMarket Cap$212.21M
Close$
Share Statistics
| Market cap | $212.21 Million |
|---|---|
| Enterprise Value | $178.97 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 164.32% |
|---|---|
| Return on Assets | 131.19% |
| Return on Invested Capital | -49.88% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 21.01 |
| Enterprise Value to EBIT | -6.73 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Profound Medical Corp
162 employees
CEO: Arun Swarup Menawat Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. Profound is commercializing TULSA-PRO®, a technology that combines real-time MR...